It is the first to compare the effectiveness of semaglutide and tirzepatide on reducing CV outcomes using a large, diverse, nationally representative database reflecting current clinical practice in patients with overweight or obesity without diabetes
Immune dysregulation in cancer patients developing immune-related adverse events
GLP-1 drugs may also interact with other medications that patients take and increase the risk of falls because of dehydration that's been associated with the drugs, said Alissa Chen, MD, an obesity specialist at the Yale School of Medicine and the first author of the review
Hypokalaemia is particularly concerning as it can cause dangerous cardiac arrhythmias
This observational study was conducted in accordance with the ethical principles of the Declaration of Helsinki [15], International Conference on Harmonization Good Clinical Practice (GCP), Good Pharmacoepidemiology Practice (GPP) [16], and all applicable laws, rules and regulations for observational studies
As seen in a case study of a severely emaciated Anorexia Nervosa patient, GHRP-2 administration led to increases in body weight, muscle mass, and fat mass